
A personalized cancer vaccine could be available as soon as 2027. Here’s what we know
A personalized mRNA vaccine for melanoma, built on the technology behind the Pfizer and Moderna COVID shots, can cut the risk of recurrence or death nearly in half. Fast Company says it could be available as soon as 2027.
Summary written by Readthrough from the original article. The full story, with photos and any updates, is at Fast Company.



